Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Google shares ease as data watchdog is latest to criticise search group

Google was back in the news on Monday as the UK data watchdog ruled that it and the NHS did not fully protect patients’ data in a recent medical trial.
Google shares ease as data watchdog is latest to criticise search group
Google shares are down 0.83% at the time of writing...

Search giant Google (NASDAQ:GOOGL) is back in the news on Monday as the UK data watchdog ruled that it and the NHS did not fully protect patients’ data in a recent medical trial.

Shares in Alphabet eased 0.83% to stand at $921.89 at the time of writing.

The transfer of 1.6 mln NHS patients' personally identifying data to Google was illegal, says the UK’s Information Commission.

Information commissioner Elizabeth Denham was precise when she summed up the case, saying there was no room for error.

“Our investigation found a number of shortcomings in the way patient records were shared for this trial,” Denham said.

“Patients would not have reasonably expected their information to have been used in this way, and the Trust could and should have been far more transparent with patients as to what was happening.”

The Royal Free NHS Trust gave the data to Google DeepMind,  which is the artificial intelligence arm of Google, for the purpose of testing a smartphone app called Streams - and did so without requesting the patients' permission.

Today's ruling follows a Sky News investigation earlier this year that showed the most senior data protection adviser to the NHS had warned the ICO that patients' data had been transferred to Google on an "inappropriate legal basis".

View full GOOG profile View Profile

Alphabet Timeline

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use